BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10473074)

  • 1. Suicide prodrugs activated by thymidylate synthase: rationale for treatment and noninvasive imaging of tumors with deoxyuridine analogues.
    Collins JM; Klecker RW; Katki AG
    Clin Cancer Res; 1999 Aug; 5(8):1976-81. PubMed ID: 10473074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl) uracil in mice bearing colorectal cancer xenografts: rationale for therapeutic use and as a positron emission tomography probe for thymidylate synthase.
    Eiseman JL; Brown-Proctor C; Kinahan PE; Collins JM; Anderson LW; Joseph E; Hamburger DR; Pan SS; Mathis CA; Egorin MJ; Klecker RW
    Clin Cancer Res; 2004 Oct; 10(19):6669-76. PubMed ID: 15475457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate Synthase.
    Li J; Kim S; Shields AF; Douglas KA; McHugh CI; Lawhorn-Crews JM; Wu J; Mangner TJ; LoRusso PM
    J Clin Pharmacol; 2016 Nov; 56(11):1433-1447. PubMed ID: 27095537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thymidylate synthase by 2',2'-difluoro-2'-deoxycytidine (Gemcitabine) and its metabolite 2',2'-difluoro-2'-deoxyuridine.
    Honeywell RJ; Ruiz van Haperen VW; Veerman G; Smid K; Peters GJ
    Int J Biochem Cell Biol; 2015 Mar; 60():73-81. PubMed ID: 25562513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
    Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
    Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil.
    Matulic-Adamic J; Takahashi K; Chou TC; Gadler H; Price RW; Reddy AR; Kalman TI; Watanabe KA
    J Med Chem; 1988 Aug; 31(8):1642-7. PubMed ID: 2840503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
    van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antitumour activity of cis- and trans-5-fluoro-5,6-dihydro-6-alkoxy-uracils; effects on thymidylate synthesis.
    van der Wilt CL; Visser GW; Braakhuis BJ; Wedzinga R; Noordhuis P; Smid K; Peters GJ
    Br J Cancer; 1993 Oct; 68(4):702-7. PubMed ID: 8398696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the study of rTS proteins. rTS expression during growth and in response to thymidylate synthase inhibitors in human tumor cells.
    Dolnick BJ; Lu K; Yin MB; Rustum YM
    Adv Enzyme Regul; 1997; 37():95-109. PubMed ID: 9381988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to thymidylate synthase as a target for cancer chemotherapy.
    Li Q; Boyer C; Lee JY; Shepard HM
    Mol Pharmacol; 2001 Mar; 59(3):446-52. PubMed ID: 11179438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic complementation and resistance to 5-fluoro-2'-deoxyuridine in thymidine auxotrophs expressing a highly defective mutant of human thymidylate synthase.
    Zapf JW; Zhao PS; Steadman DJ; Berger SH
    Biochem Pharmacol; 1999 Sep; 58(6):973-81. PubMed ID: 10509749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2'-deoxyuridine.
    Davis ST; Berger SH
    Mol Pharmacol; 1993 May; 43(5):702-8. PubMed ID: 8502227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
    Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
    Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymidylate synthase: a critical target in cancer therapy?
    Rustum YM
    Front Biosci; 2004 Sep; 9():2467-73. PubMed ID: 15353299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency.
    Houghton PJ; Germain GS; Hazelton BJ; Pennington JW; Houghton JA
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1377-81. PubMed ID: 2537495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.